Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)
Why established systems and relationships matter
HLA matching could bring more allogeneic cell therapies to market, faster
An expert opinion on HLA matching relevance for allogeneic cell therapies
Cell collection standards for cell therapies
A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies
How to overcome 3 common cell therapy supply chain disruptions
Design a tailored logistics plan to deliver
Driving CAR-T therapy safety and sustainability for the road ahead
Q&A with Abby McDonald, PhD, Solutions Development Supervisor
An opportunity to impact the future of medicine
As told by Leah, Be The Match BioTherapies® allogeneic donor
The benefits of a Quality System Audit Program
Accelerate patient access to cell and gene therapies
Standardization in cell therapy industry is a race against time
Accellerate Summit highlights needs and challenges in standardization